Truist cuts iRhythm Technologies stock price target on valuation

robot
Abstract generation in progress

Truist Securities has lowered its price target for iRhythm Technologies (NASDAQ:IRTC) to $200 from $215, while maintaining a Buy rating. This adjustment comes despite the company’s strong fourth-quarter revenue performance and positive GAAP net income, reflecting a valuation correction due to lower group multiples. iRhythm’s innovative products and strategic growth targets suggest continued market adoption, with its MCT product on track for 2027 and a projected $1 billion in revenue and 15% EBITDA margin by the same year.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)